PIVONELLO, ROSARIO
 Distribuzione geografica
Continente #
AS - Asia 17.105
NA - Nord America 13.341
EU - Europa 10.781
SA - Sud America 2.196
AF - Africa 423
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 13
Totale 43.882
Nazione #
US - Stati Uniti d'America 12.768
SG - Singapore 7.716
RU - Federazione Russa 5.238
CN - Cina 3.290
VN - Vietnam 2.974
BR - Brasile 1.736
HK - Hong Kong 1.453
IT - Italia 1.410
DE - Germania 834
FR - Francia 607
FI - Finlandia 535
NL - Olanda 508
SE - Svezia 388
IE - Irlanda 321
CA - Canada 301
GB - Regno Unito 290
IN - India 276
UA - Ucraina 258
JP - Giappone 226
MX - Messico 173
AR - Argentina 170
BD - Bangladesh 155
KR - Corea 145
IQ - Iraq 123
TR - Turchia 106
CI - Costa d'Avorio 101
PL - Polonia 89
EC - Ecuador 87
ZA - Sudafrica 87
ID - Indonesia 86
PH - Filippine 84
ES - Italia 76
TH - Thailandia 68
CO - Colombia 53
PK - Pakistan 51
KE - Kenya 45
TW - Taiwan 43
AT - Austria 40
VE - Venezuela 35
UZ - Uzbekistan 33
EG - Egitto 32
CL - Cile 31
TN - Tunisia 31
JO - Giordania 30
MA - Marocco 30
PY - Paraguay 30
IL - Israele 28
SA - Arabia Saudita 28
LT - Lituania 26
IR - Iran 24
AE - Emirati Arabi Uniti 22
BE - Belgio 21
CZ - Repubblica Ceca 19
UY - Uruguay 19
DZ - Algeria 18
LB - Libano 17
PE - Perù 17
PT - Portogallo 16
AU - Australia 15
BO - Bolivia 15
CR - Costa Rica 15
ET - Etiopia 14
JM - Giamaica 14
NP - Nepal 14
AZ - Azerbaigian 13
RO - Romania 13
HN - Honduras 12
CH - Svizzera 11
MY - Malesia 11
OM - Oman 10
SY - Repubblica araba siriana 10
DO - Repubblica Dominicana 9
PA - Panama 9
LV - Lettonia 8
PS - Palestinian Territory 8
GR - Grecia 7
KZ - Kazakistan 7
NG - Nigeria 7
NI - Nicaragua 7
TT - Trinidad e Tobago 7
AF - Afghanistan, Repubblica islamica di 6
AL - Albania 6
HU - Ungheria 6
KW - Kuwait 6
SN - Senegal 6
AM - Armenia 5
BA - Bosnia-Erzegovina 5
BB - Barbados 5
BG - Bulgaria 5
BH - Bahrain 5
BY - Bielorussia 5
HR - Croazia 5
KG - Kirghizistan 5
MD - Moldavia 5
SI - Slovenia 5
BF - Burkina Faso 4
BS - Bahamas 4
BW - Botswana 4
CG - Congo 4
CW - ???statistics.table.value.countryCode.CW??? 4
Totale 43.754
Città #
Singapore 3.705
San Jose 2.617
Hong Kong 1.419
Moscow 1.274
Chandler 1.124
Ashburn 924
Ho Chi Minh City 890
Beijing 832
Hanoi 620
Hefei 610
Santa Clara 518
Millbury 473
The Dalles 432
Amsterdam 426
Naples 395
Lauterbourg 391
Los Angeles 328
Princeton 303
Munich 283
Jacksonville 273
Nanjing 259
Buffalo 205
Wilmington 198
Tokyo 195
Boston 169
São Paulo 159
Redondo Beach 149
New York 147
Napoli 138
Da Nang 131
Des Moines 124
Helsinki 120
Ottawa 118
Turku 116
Dallas 114
Seoul 106
Haiphong 105
Frankfurt am Main 97
Orem 93
Houston 87
Woodbridge 84
Seattle 81
Boardman 79
Lawrence 78
Nanchang 77
Montreal 72
Warsaw 72
Mexico City 68
Chicago 67
Rome 67
Falkenstein 61
Hebei 58
Nuremberg 52
Rio de Janeiro 52
Atlanta 51
Brooklyn 50
Denver 50
Biên Hòa 48
Chennai 48
Council Bluffs 48
Phoenix 48
Tianjin 48
London 47
Johannesburg 46
Stockholm 45
Hải Dương 43
San Francisco 43
Shenyang 43
Baghdad 42
Nairobi 42
Poplar 42
Toronto 42
Manchester 40
Ann Arbor 37
Changsha 37
Can Tho 35
Curitiba 35
Norwalk 34
Jiaxing 33
Shanghai 33
Ankara 32
Brasília 32
Belo Horizonte 31
Kochi 31
Kronberg 31
Quito 30
Tashkent 30
Porto Alegre 29
Falls Church 28
New Delhi 28
Ninh Bình 28
Dhaka 27
Milan 27
San Mateo 27
Dublin 26
Guayaquil 26
Thái Nguyên 24
Campinas 23
Guangzhou 23
Mumbai 23
Totale 23.301
Nome #
Effects of Chrono-Exercise and Chrono-Nutrition on Muscle Health: Understanding the Molecular Mechanisms Activated by Timed Exercise and Consumption of Proteins and Carbohydrates 230
Medical consequences of acromegaly: what are the effects of biochemical control? 220
A New Clinical Model to Estimate the Pre-Test Probability of Cushing’s Syndrome: The Cushing Score 212
Spot-light on microbiota in obesity and cancer 211
Exposure to artificial light at night: A common link for obesity and cancer? 183
Sulfur amino acids in Cushing's disease: insight in homocysteine and taurine levels in patients with active and cured disease 177
The role of vitamin D in male fertility: A focus on the testis 177
Effect of the acute administration of the Dopamine Agonist Cabergoline on glucose tolerance and Insuline Sensitivity in patient with obesity. 175
Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age 174
Short-term effects of growth hormone (GH) treatment or deprivation on cardiovascular risk parameters and intima-media thickness at carotid arteries in patients with severe GH deficiency 169
The 17β-hydroxysteroid dehydrogenase type 3 deficiency: a case report of an 18-year patient and review of the literature. 169
The association of fasting insulin concentrations and colonic neoplasms in acromegaly: a colonoscopy-based study in 210 patients 167
Vein wall thickness and severity of pulmonary involvement due to sars n-cov2 virus infection 162
MicroRNAs and Long Non-Coding RNAs in Adrenocortical Carcinoma 161
Growth hormone-secreting tumor shrinkage after 3 months of octreotide-long-acting release therapy predicts the response at 12 months. 161
Association between vitamin D and sperm parameters: Clinical evidence 161
Flavor perception test: evaluation in patients with Kallmann syndrome 160
Long-term high-dose l-arginine supplementation in patients with vasculogenic erectile dysfunction: a multicentre, double-blind, randomized, placebo-controlled clinical trial 157
Bisphenol A: An emerging threat to female fertility 156
Selenium supplementation modulates apoptotic processes in thyroid follicular cells 155
Circulating myomiRNAs as biomarkers in patients with Cushing's syndrome 154
Neuropsychiatric disorders in Cushing's syndrome. 154
Correlation between Morphometric parameters and chromatin fragmentation in spermatozoa of Canis familiaris. 154
Reduced bone mineral density in glycogen storage disease type III: Evidence for a possible connection between metabolic imbalance and bone homeostasis 153
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients. 151
The treatment with growth hormone receptor antagonist in acromegaly: effect on vascular structure and function in patients resistant to somatostatin analogues. 150
Circadian rhythm of glucocorticoid administration entrains clock genes in immune cells: a DREAM trial ancillary study 150
Octreotide-LAR vs lanreotide-SR as first-line therapy for acromegaly: A retrospective, comparative, head-to-head study 149
Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism 148
Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly. 148
Cardiovascular consequences of early-onset growth hormone excess 148
The spectrum of cardiac abnormalities in patients with acromegaly: results from a case-control cardiac magnetic resonance study 147
Somatostatin analogs in treatment of non-growth hormone-secreting pituitary adenomas 147
Effects of long-term combined treatment with somatostatin analogues and pegvisomant on cardiac structure and performance in acromegaly 147
Hypertension in acromegaly and in the normal population: prevalence and determinants 146
Growth hormone excess with onset in adolescence: clinical appearance and long-term treatment outcome 146
Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males 146
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE). 146
The natural history of partial growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis. 145
The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma 145
Air pollution and female fertility: A systematic review of literature 145
The role of melatonin in the molecular mechanisms underlying metaflammation and infections in obesity: A narrative review 144
The treatment with pasireotide in Cushing's disease: effects of long-term treatment on tumor mass in the experience of a single center. 142
Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation. 141
The environment and male reproduction: The effect of cadmium exposure on reproductive functions and its implication in fertility 141
Acromegaly and the cardiovascular system 141
Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly 140
Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy. 139
High prevalence of cardiac valve disease in acromegaly: an observational, analytical, case-control study 139
Cushing's syndrome: aftermath of the cure. 139
Severe impact of late diagnosis of congenital adrenal hyperplasia on gender identity, sexual orientation and function: case report and review of the literature 138
New perspectives in the medical treatment of acromegaly 138
Weekly clodronate treatment prevents bone loss and vertebral fractures in womenwith subclinical Cushing's syndrome. 138
Erratum to: The treatment with pasireotide in Cushing’s disease: effects of long–term treatment on tumor mass in the experience of a single center (Endocrine, (2015), 50, (725-740) DOI 10.1007/s12020-015-0557-2) 138
The effect of FT500 Plus® on ovarian stimulation in PCOS women 138
CORTISOL CIRCADIAN RHYTHM AND INSULIN RESISTANCE IN MUSCLE: EFFECT OF DOSING AND TIMING OF HYDROCORTISONE EXPOSURE ON INSULIN SENSITIVITY IN SYNCHRONIZED MUSCLE CELLS 138
Impact of Somatostatin Analogs vs. Surgery on glucose metabolism in acromegaly: Results of a 5 years observational, open, prospective study 137
Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients 137
Cardiac effect of thyrotoxicosis in acromegaly 137
Pathophysiology of diabetes mellitus in Cushing's syndrome. 137
The Glucocorticoid Analog Dexamethasone Alters the Expression and the Distribution of Dopamine Receptors and Enkephalin within Cortico-subcortical Regions. 137
Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375/oncogenes circuit 137
Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance 136
A longitudinal study of vasopressin cell antibodies, posterior pituitary function, and magnetic resonance imaging evaluations in subclinical autoimmune central diabetes insipidus 136
Shedding new light on female fertility: The role of vitamin D 136
Tumor necrosis factor-alpha increases after corticotropin-releasing hormone administration in Cushing's disease. In vivo and in vitro studies. 135
The Treatment of Cushing's Disease. 134
Evaluation of morphometric parameters and chromatin integrity in the sperm of stallion food supplemented with Maca. 134
Adverse events associated with somatostatin analogs in acromegaly. 133
Acromegalic axial arthropathy: a clinical case-control study 133
Multiple system atrophy is associated with changes in peripheral insulin-like growth factor system. 133
17 beta hyrossisteroid dehydrogenase type 3 deficiency : a new case of a rare disease with uncommon gene mutation 132
Effect of Chronic Cabergoline Treatment and Testosterone Replacement on Metabolism in Male Patients with Prolactinomas 132
[Chronic kidney disease: fertility and sexuality] 131
The Interplay Between Prolactin and Reproductive System: Focus on Uterine Pathophysiology 131
Fertility in Acromegaly: a single center experience on female patients during active disease and after disease remission 130
Effect of gender and gonadal status on the long-term response to somatostatin analogue treatment in acromegaly 130
Metabolic alterations and cardiovascular outcomes of cortisol excess 130
1,25‑Dihydroxyvitamin D3 mitigates the adipogenesis induced by bisphenol A in 3T3-L1 and hAMSC through miR-27-3p regulation 129
CONVENTIONAL AND NUCLEAR MEDICINE IMAGING IN ECTOPIC CUSHING'S SYNDROME: A SYSTEMATIC REVIEW. 129
Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: comparison with the effectiveness of cabergoline treatment 129
Effect of Cabergoline on Metabolism in Prolactinomas. 129
Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials 129
Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission 128
The pituitary uptake of (111)In-DTPA-D-Phe1-octreotide in the normal pituitary and in pituitary adenomas 128
Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure 128
The role of somatostatin analogs in the management of hepatocellular carcinoma 128
The Vaginal Microbiome: A Long Urogenital Colonization Throughout Woman Life 128
Insulin-like growth factor-1 deficiency determines increased intima-media thickness at common carotid arteries in adult patients with growth hormone deficiency 127
Complete disappearance of a GH-secreting pituitary macroadenoma in a patient with acromegaly: effect of treatment with lanreotide Autogel and consequence of treatment withdrawal. 127
The role of dopamine pathway on human sperm: in vitro effect of dopamine receptor agonists and antagonists on sperm motility, kinetics and viability 127
Imbalanced cortisol concentrations in glycogen storage disease type I: Evidence for a possible link between endocrine regulation and metabolic derangement 127
Is diabetes in Cushing's syndrome only a consequence of hypercortisolism? 126
First-line octreotide-LAR therapy induces tumour shrinkage and controls hormone excess in patients with acromegaly: results from an open, prospective, multicentre trial. 125
Growth hormone nadir during oral glucose load depends on waist circumference, gender and age: normative data in 231 healthy subjects. 125
The kidney in acromegaly: renal structure and function in patients with acromegaly during active disease and 1 year after disease remission. 125
Vitamin D Reverts the Exosome-Mediated Transfer of Cancer Resistance to the mTOR Inhibitor Everolimus in Hepatocellular Carcinoma 125
Cardiovascular alterations in adult GH deficiency 124
Impairment of bone status in patients with central diabetes insipidus 123
Approach to the Patient with Prolactinoma 122
Totale 14.486
Categoria #
all - tutte 137.631
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 137.631


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021199 0 0 0 0 0 0 0 0 0 32 134 33
2021/20222.214 37 7 10 25 54 215 29 61 372 120 376 908
2022/20232.709 409 227 75 213 329 262 27 230 374 414 112 37
2023/20241.766 86 271 239 142 80 115 49 190 26 36 313 219
2024/202511.809 632 758 99 95 252 584 1.326 761 859 1.053 4.298 1.092
2025/202622.652 2.578 1.855 2.431 2.103 4.015 917 2.936 1.403 3.107 1.307 0 0
Totale 44.523